Primobolan vs Trenbolone
Well Studied vs Moderate Research
avoid Mechanism-based · 64% Both Primobolan and Trenbolone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
Primobolan Trenbolone
Weight 302.45 Da (base) 270.37 Da (base)
Half-life ~10 days (enanthate) ~3 days (acetate)
Type DHT-derivative steroid (C20H30O2) 19-nortestosterone derivative (C18H22O2), trienone steroid
Key Benefits
Primobolan
01 Lean muscle mass preservation during caloric deficits with minimal water retention
02 Does not aromatize to estrogen, eliminating estrogen-related side effects
03 One of the mildest androgenic profiles among anabolic steroids, with reduced risk of acne, aggression, and prostate issues
04 Injectable form is non-hepatotoxic, allowing extended cycle durations
05 Strong anti-catabolic properties through glucocorticoid receptor modulation
06 Immune-enhancing effects at moderate therapeutic doses
07 Quality, keepable muscle gains without the bloated appearance common with aromatizing steroids
08 Compatible with long cycle lengths (16-20 weeks) due to mild overall impact on health markers
Trenbolone
01 Exceptional lean muscle mass accrual with minimal water retention due to non-aromatizing profile
02 Dramatic body recomposition capability -- simultaneous muscle gain and fat loss even in caloric deficit
03 Approximately five times the anabolic and androgenic potency of testosterone (500:500 ratio)
04 Powerful anti-catabolic effects through glucocorticoid receptor antagonism, protecting muscle during dieting
05 Significant increases in strength across all compound movements, often rapid in onset
06 Enhanced nutrient partitioning, directing calories toward lean tissue accretion over fat storage
07 Pronounced muscle hardness, density, and vascularity due to absence of estrogenic water retention
08 Increased IGF-1 production in muscle tissue, amplifying growth signaling pathways
Dosing Protocols
Primobolan
400-800 mg/week (injectable) or 50-100 mg/day (oral) / 1-2x per week (enanthate) or daily (oral acetate)
Lean Mass Preservation - Cutting 400-600 mg/week 2x per week (split dose)
Lean Bulking 600-800 mg/week 2x per week (split dose)
Female Protocol 50-100 mg/week 1x per week
Trenbolone
200-400 mg/week / Every other day (acetate) or 2x per week (enanthate)
Recomposition - Moderate (Acetate) 200-300 mg/week (50-75 mg every other day) Every other day
Advanced Cutting (Acetate) 300-400 mg/week (75-100 mg every other day) Every other day
Lean Bulk (Enanthate) 200-400 mg/week 2x per week
Contest Preparation - Advanced 300-500 mg/week Every other day (acetate) or 2x per week (enanthate)
Side Effects
Primobolan
Suppression of natural testosterone production (dose-dependent, less suppressive than many other anabolic steroids but still significant)
Hair thinning or accelerated male pattern baldness (DHT derivative -- this is the most commonly reported side effect in susceptible individuals)
Adverse lipid changes, particularly HDL suppression (moderate compared to other anabolic steroids)
Mild acne or oily skin (less pronounced than testosterone or other androgens)
Injection site discomfort from larger oil volumes required at performance doses
Gradual decline in natural testosterone production requiring post-cycle therapy
Trenbolone
Insomnia and severely disrupted sleep architecture (one of the most universally reported side effects, affecting the majority of users)
Night sweats, often drenching, requiring sheet changes
Significantly reduced cardiovascular endurance and aerobic capacity
Increased aggression, irritability, and shortened temper
Anxiety and restlessness, particularly at higher doses
Tren cough: acute, intense coughing fit lasting 30-90 seconds immediately after injection, caused by a small amount of oil entering a blood vessel
Dark-colored urine (oxidized metabolites; not necessarily indicative of kidney damage but should be monitored)
Elevated body temperature and increased sweating throughout the day
Acne and oily skin, particularly on shoulders, back, and chest
Accelerated hair loss in those genetically predisposed to male pattern baldness
Profoundly suppressive of natural testosterone production (near-complete HPT axis shutdown)
Increased heart rate and elevated blood pressure
Contraindications
Prostate cancer (active or history of hormone-sensitive prostate cancer)
Breast cancer in males or females
Pregnancy or potential for pregnancy (teratogenic risk -- fetal virilization)
Severe hepatic impairment (particularly relevant for oral acetate form)
Known hypersensitivity to metenolone or formulation components
Hypercalcemia
Polycythemia (hematocrit above 54% at baseline)
Uncontrolled cardiovascular disease or severe dyslipidemia
First steroid cycle or limited anabolic steroid experience (trenbolone is strictly an advanced-only compound)
Pre-existing cardiovascular disease, cardiomyopathy, or significant cardiac risk factors
History of mental health conditions: anxiety disorders, depression, bipolar disorder, or psychotic episodes
Liver disease or significantly elevated liver enzymes
Kidney disease or impaired renal function
Uncontrolled hypertension
Polycythemia (hematocrit above 54% at baseline)
Prostate cancer or history of hormone-sensitive cancers
Active or recent substance abuse (trenbolone's psychological effects can exacerbate addictive behaviors)
Pregnancy or potential for pregnancy in female partners (extremely virilizing compound)
Research Evidence
Primobolan Trenbolone
Status Well Studied Moderate Research
References 4 studies 5 studies
Latest January 2017 January 2023
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.